发明名称 |
METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINE |
摘要 |
The invention relates to glucagon-related peptides and their use for the prevention or treatment of disorders involving the large intestine. In particular, it has now been demonstrated that GLP-2 and peptidic agonists of GLP-2 can cause proliferation of the tissue of large intestine. Thus, the invention provides methods of proliferating the large intestine in a subject in need thereof. Further, the methods of the invention are useful to treat or prevent inflammatory conditions of the large intestine, including inflammatory bowel diseases. |
申请公布号 |
US2015290295(A1) |
申请公布日期 |
2015.10.15 |
申请号 |
US201514685363 |
申请日期 |
2015.04.13 |
申请人 |
1149336 Ontario Inc. |
发明人 |
Drucker Daniel J. |
分类号 |
A61K38/26;A61K49/00;C07K14/605 |
主分类号 |
A61K38/26 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating a subject to enhance functioning of the large intestine, comprising the step of delivering to the large intestine of the subject a GLP-2 receptor agonist in an amount effective to enhance functioning of the large intestine. |
地址 |
Toronto CA |